- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Adherence with urate-lowering therapies for the treatment of gout ; volume:11 ; number:2 ; day:27 ; month:3 ; year:2009 ; pages:1-7 ; date:4.2009
Arthritis Research & Therapy ; 11, Heft 2 (27.3.2009), 1-7, 4.2009
- Creator
-
Harrold, Leslie R.
- Contributor
-
Andrade, Susan E.
Briesacher, Becky A.
Raebel, Marsha A.
Fouayzi, Hassan
Yood, Robert A.
Ockene, Ira S.
SpringerLink (Online service)
- DOI
-
10.1186/ar2659
- URN
-
urn:nbn:de:1111-2016050311922
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Harrold, Leslie R.
- Andrade, Susan E.
- Briesacher, Becky A.
- Raebel, Marsha A.
- Fouayzi, Hassan
- Yood, Robert A.
- Ockene, Ira S.
- SpringerLink (Online service)
Other Objects (12)
Variation in serum urate levels in the absence of gout and urate lowering therapy
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
Variation in serum urate levels in the absence of gout and urate lowering therapy
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
Variation in serum urate levels in the absence of gout and urate lowering therapy
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout
Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment